1. Chugun, A., Sato, O.,
Takeshima, H. & Ogawa, Y. Mg2+ activates the ryanodine
receptor type 2 (RyR2) at intermediate Ca2+ concentrations. Am.
J. Cell Physiol. 292, C535-544, 2007.
2. Miyakawa, K., Uchida, A., Shiraki, T., Teshima, K., Takeshima, H. & Shibata,
S. ORL1 receptor-mediated down-regulation of mRER2 in the suprachiasmatic nucleus
accelerates re-entrainment of the circadian clock following a shift in the environmental
light/dark cycle. Neuropharmacol. 52, 1055-1064, 2007.
3. Nagai, J., Kurokawa, M., Takeshima, H., Kieffer, B. L. & Ueda, H. Nociceptin
receptor (NOP)-deficient mice show memory and learning enhancement in a novel
KUROBOX apparatus using stress-free positive cue task. J. Pharmacol.
Exp. Ther. 321, 195-201, 2007.
4. Phimister, A. J., Lango, J., Lee, E. H., Ernst-Russell, M., Takeshima, H.,
Ma, J., Allen, P. D. & Pessah, I. N. Conformation-dependent stability of
junctophilin 1 (JP1) and ryanodine receptor type 1 (RyR1) channel complex is
mediated by their hyper-reactive thiols. J. Biol. Chem. 282,
8667-8677, 2007.
5. Weisleder, N., Ferrante, C., Hirata, Y., Collet, C., Chu, Y., Cheng, H., Takeshima,
H. & Ma, J. Systemic ablation of RyR3 alters Ca2+ spark signaling in adult
skeletal muscle. Cell Calcium in press.
6. Hotta, S., Morimura, K., Ohya, S., Muraki, K., Takeshima, H. & Imaizumi,
Y. Ryanodine receptor type 2 deficiency changes excitation-contraction coupling
and membrane potential in urinary bladder smooth muscle. J. Physiol. in
press.
7. Matsushita, Y., Furukawa, T., Kasanuki, H., Nishibatake,
M., Kurihara, Y., Ikeda, A., Kamatani, N., Takeshima, H. & Matsuoka,
R. Mutations of junctophilin type 2 associated with hypertrophic
cardiomyopathy. J. Hum. Genet. 52,
543-548, 2007. |
